IMVT Key Financial Ratios - Immunovant, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	7.27	—	-63.13%	-73.19%
2026-03-31	9.09	—	-52.83%	-59.30%
2025-12-31	15.74	—	-44.11%	-47.07%
2025-09-30	9.07	—	-79.71%	-89.41%
2025-06-30	12.32	—	-67.63%	-73.50%
2025-03-31	11.16	—	-53.31%	-58.50%
2024-12-31	6.04	—	-90.92%	-108.53%
2024-09-30	7.61	—	-62.63%	-71.93%
2024-06-30	13.08	—	-46.22%	-50.04%
2024-03-31	13.7	—	-38.92%	-41.98%
2023-12-31	22.14	—	-34.22%	-35.84%
2023-09-30	7.23	—	-87.40%	-101.37%
2023-06-30	6.82	—	-69.62%	-81.54%
2023-03-31	9.34	—	-51.98%	-58.20%
2022-12-31	11.01	—	-43.55%	-47.92%
2022-09-30	13.41	—	-41.31%	-44.69%
2022-06-30	21.48	—	-36.33%	-38.18%
2022-03-31	11.52	—	-30.40%	-33.36%
2021-12-31	14.87	—	-25.35%	-27.26%
2021-09-30	19.86	—	-22.60%	-23.88%
2021-06-30	18.75	—	-28.66%	-30.42%
2021-03-31	21.79	—	-26.04%	-27.44%
2020-12-31	26.05	—	-23.05%	-24.10%
2020-09-30	35.15	—	-17.48%	-18.10%
2020-06-30	14.64	—	-25.16%	-27.28%
2020-03-31	7.12	—	-60.69%	-70.57%
2019-12-31	—	—	-43.33%	-49.05%
2019-09-30	5.22	—	-44.51%	225.15%
2019-06-30	22.77	—	-37.72%	365.79%
2019-03-31	41.87	—	-206.82%	-389.69%
2018-12-31	0.85	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2026-03-31	9.09	—	-52.83%	-59.30%
2025-03-31	11.16	—	-53.31%	-58.50%
2024-03-31	13.7	—	-38.92%	-41.98%
2023-03-31	9.34	—	-51.98%	-58.20%
2022-03-31	11.52	—	-30.40%	-33.36%
2021-03-31	21.79	—	-26.04%	-27.44%
2020-03-31	7.12	—	-60.69%	-70.57%
2019-03-31	—	—	-206.82%	-389.69%